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SUMMARY
A serosurvey of 349 military working horses and 231 military working dogs was conducted in ten sites
in Morocco in 2012. This survey revealed a high level of exposure of these animals to ﬂaviviruses:
seroprevalence rates of 60% in horses and of 62% in dogs were observed using a competitive West
Nile virus (WNV) enzyme-linked immunosorbent assay (cELISA). Seroneutralization test results
showed that the majority of cELISA-positive results were due to exposure to WNV. Further assays
conducted in vaccinated horses with a DIVA (Differentiating Infected from Vaccinated Animals) test
indicated that anti-WNV antibodies had been stimulated through WNV natural infection. Moreover,
in both species, seroneutralization tests suggested an exposure to Usutu virus (USUV). Data analysis
did not show any signiﬁcant difference of cELISA seropositivity risk between horses and dogs. Dogs
may thus represent an interesting alternative to equines for the serological surveillance of WNV or
USUV circulation, especially in areas where equine vaccination precludes passive surveillance (based
on the detection of West Nile fever cases) in horses.
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INTRODUCTION
West Nile virus (WNV) is a mosquito-borne virus of
the genus Flavivirus, family Flaviviridae. The geo-
graphical distribution of this virus is very large as its
circulation has been reported in most of the continents
(except Antarctica). Birds are the reservoir of the virus
and its natural transmission cycle involves
mosquitoes. Humans and horses show a short-term
viraemia at low levels, and are thus considered dead-
end hosts. WNV causes West Nile fever (WNF) in
both species, characterized by a febrile illness, which
may progress to a meningoencephalitic syndrome in
a small proportion of cases. In Morocco, WNF was
ﬁrst reported in 1996, with 94 equine cases of which
42 died [1]. WNF was again reported in equines in
2003 (nine cases of which ﬁve died) [2] and in 2010
(25 cases of which eight died) [3] (Fig. 1). A serosurvey
conducted in 2008 showed that WNV did circulate in
Moroccan resident bird populations [4]. Recently, in
the absence of clinical cases, signiﬁcant seroprevalence
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rates for WNV (5–19%, seroneutralization assay) have
been reported in humans in several Moroccan pro-
vinces [5, 6]. Usutu virus (USUV) probably circulates
in Morocco, as serological evidence of infection has
been reported in wild birds, although at a lower
level than for WNV [4]. Other ﬂaviviruses circulate
in Africa but none has ever been reported in
Morocco. African areas with risk of yellow fever
virus transmission are restricted to sub-Saharan coun-
tries [7], and this is also the case for laboratory-
conﬁrmed cases of dengue virus infection [8].
Similarly, Koutango virus has only been isolated
south of the Sahara, in Senegal and Somalia, and
Bagaza virus has been isolated in Western and
Central Africa. Wesselbron virus infection appears en-
demic in Southern Africa [9], and Zika virus has never
been isolated in Maghreb (http://www.cdc.gov/zika/
geo/index.html). The circulation of WNV is seasonal
in Maghreb, with outbreaks in summer and autumn.
It is also probably the case for USUV but the epidemi-
ology of this virus in Africa is less well known [10].
Although some ﬁeld studies have reported clinical
cases of WNF in canids [11–13], experimental studies
failed to reproduce the disease in the dog model [14,
15] and the short-term and low-level viraemia [14]
makes it unlikely that dogs play a role in the WNV epi-
demiological cycle. Several studies have reported signiﬁ-
cant WNV seroprevalence rates in dogs in Africa [15,
16], Europe [16, 17], Turkey [18], the United States
[19–23] and China [24]. Moreover, in the United
States, antibodies were detected in a population of
young dogs several weeks before the ﬁrst reported
human cases [25]. This suggests that dogs may be useful
as sentinels providing early warning of virus circulation.
The serological study reported here had two objec-
tives: (i) to evaluate the extent of past WNV
Fig. 1. Map of the study area showing the location of the military sites where animals were sampled (.) or where they
had been stationed during their military career (◦) (dark grey shading: areas where clinical cases were reported in horses in
1996, 2003 and/or 2010, lines: province boundaries; A, Agadir; B, Ain el Aouda; C, Benguerir; D, Ben Slimane;
E, Casablanca; F, Tadla; G, Kenitra; H, Khenifra; I, Laâyoune; J, Marrakhech; K, Meknes; L, Oujda; M, Rabat;
N, Saﬁ; O, Salé; P, Sidi Slimane; Q, Temara).
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circulation in Morocco, using horses as sentinels, and
(ii) to analyse the relevance of dogs as sentinels of past
WNV circulation, in comparison with horses. The
study focused on military working animals (horses
and dogs), for which service record books allowed a
precise reconstruction of the military career of each
animal. Serum samples were tested for antibodies
against WNV and USUV.
MATERIALS AND METHODS
Animal samples
Moroccan military horses and/or dogs were stationed
in 18 sites, among which 10 were selected for the study
(Table 1, Fig. 1), based on the number of animals sta-
tioned (n > 20), and for practical reasons (geographic-
al distance and accessibility). In order to compare
dogs and horses as sentinels of past WNV circulation,
ﬁve sites were selected in areas affected by previous
epizootics of WNV (Kenitra, Khenifra, Benslimane,
Sidi Slimane, Casablanca), and which housed both
working horses and dogs. The ﬁve other sites were
selected in areas where no WNF clinical case had
ever been reported (Temara, Meknes, Marrakech,
Agadir, Salé), in order to evaluate the extent of past
WNV circulation in Morocco: in these sites, only
equine samples were analysed. All the military work-
ing horses and dogs present at each of these ten sites
were included in the study, except for Khenifra and
Temara where the horse population was large (281
and 261 animals, respectively) and ∼100 animals
were randomly selected. The animals were blood-
sampled in February 2012. Data collected for each
animal of the study included the birth date, species
and sex (stallion or male, vs. gelding or female).
Service record books were screened for reconstructing
the military career of the animal with, for each of its
successive postings, the site and the arrival and de-
parture dates. The dates of WNV vaccinations of
horses were also collected. The whole study was
designed and conducted in collaboration with the
Moroccan Army. Data collection, ﬁeld samples and
protocols were performed by a veterinarian from the
Royal Armed Forces, in accordance with the
Moroccan regulations regarding animal welfare.
Serological tests
Competitive enzyme-linked immunosorbent assay
(cELISA)
Serological screening of horse and dog sera was per-
formed using a cELISA test (ID Screen® West Nile
Competition ELISA kit, ID Vet, France). Assays
were performed and interpreted according to the
manufacturer’s instructions. The threshold value
for considering a serum as positive was %OD sam-
ple/negative control (S/N) <40% as recommended
by the manufacturer. This test is often used for iden-
tifying anti-WNV immunoglobulins, but cross-
reactions with other ﬂaviviruses have been described
[26–29]. Therefore a positive result was interpreted
as indicating the presence of immunoglobulins
directed against a ﬂavivirus (either WNV or other
ﬂaviviruses).
Table 1. Flavivirus seroprevalence, estimated by WNV cELISA, in military horses and dogs, Morocco, 2012
Horses Dogs
Positive (tested) Prevalence (95% CI) Positive (tested) Prevalence (95% CI)
Agadir 13 (20) 0·65 (0·41–0·85)
Benslimane* 1 (4) 0·25 (0·01–0·81) 101 (186) 0·54 (0·47–0·62)
Casablanca* 3 (4) 0·75 (0·19–0·99)
Kenitra* 31 (38) 0·82 (0·66–0·92) 22 (23) 0·96 (0·78–1·00)
Khenifra* 30 (102) 0·29 (0·21–0·39) 3 (4) 0·75 (0·19–0·99)
Marrakech 6 (19) 0·32 (0·13–0·57)
Meknes 14 (41) 0·34 (0·20–0·51)
Salé 3 (6) 0·50 (0·12–0·88)
Sidi Slimane* 7 (7) 1·00 (0·59–1·00) 17 (18) 0·94 (0·73–1·00)
Temara 101 (108) 0·94 (0·87–0·97)
Total 209 (349) 0·60 (0·55–0·65) 143 (231) 0·62 (0·55–0·68)
CI, Conﬁdence interval.
* Provinces in which West Nile fever cases have been reported in horses in 1996, 2003 and/or 2010.
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WNV non-structural protein 1(NS1)-ELISA (DIVA
test)
Equine serum samples positive by WNV cELISA
were screened using an in-house epitope-blocking
ELISA as developed by Blitvich et al. [30].
MaxiSorp 96-well ELISA plates (Nunc,
Dutscher-Scientiﬁc, UK) were coated with
WNV-inactivated antigens (kindly provided by Dr
P. Desprès, Pasteur Institute) diluted 1:1000 in coat-
ing buffer (50 mM NaHCO3, 50 mM Na2CO3, pH
9·6) (VWR BDH-Prolabo, UK). A total of 100 µl
diluted antigen was distributed in even columns,
while 100 µl coating buffer alone was distributed
in odd columns. Plates were incubated overnight
at 4 °C as well as for 1 h at 37 °C on a plate shaker.
Wells were washed four times with 0·1% Tween 20
in PBS (pH 7·4) (washing solution, Gibco, Life
Technologies, USA). A total of 200 µl blocking buf-
fer containing 0·2% bovine serum albumin (Sigma,
USA) in washing buffer were added. Plates were
incubated for 45 min at 37 °C under agitation and
washed three times. Serum samples as well as posi-
tive and negative controls (NC), diluted 1:10 in
blocking buffer, were added to the wells and incu-
bated for 2 h at 37 °C under agitation. After four
washing steps, 50 µl mouse anti-WNV NS1 mono-
clonal antibody (MAB8152, 3·1112 G clone,
Merck Millipore, USA) diluted 1:4000 in blocking
buffer was added to the wells, and incubated for 1
h at 37 °C under agitation, and for an additional
1 h at 4 °C. After four washing steps, F(ab′)2 rabbit
anti-mouse IgG antibodies conjugated to horserad-
ish peroxidase (Star 13B, Serotec, USA) were
diluted 500-fold in blocking buffer with 10% of
heat-inactivated horse serum (Gibco) and incubated
for 1 h at 37 °C under agitation. After four washing
steps, 200 µl TMB (Sigma) diluted 1:10 in phosphate
citrate buffer was added to the wells. After 30 min
incubation at 37 °C on a plate shaker, the reaction
was stopped by adding 100 µl H2SO42N
(Normapur Prolabo) in each well. The optical dens-
ity (OD) was read at 450 nm with an ELISA micro-
well plate reader (Thermo Scientiﬁc Multiskan EX,
USA). Blocking percentages were determined for
each sample as
S/N = 100× (ODeven column −ODodd column)(OD NCodd column −OD NCeven column) .
A sample was considered positive if S/N <30%.
Virus-speciﬁc microneutralization tests (MNTs)
To identify the circulating ﬂaviviruses, WNV and
USUV MNTs were performed on cELISA-positive
sera: for each of the tenmilitary sites and for both studied
species, all of the cELISA-positive sera were tested, with
amaximumof 20 randomly selected sera per site and per
species. WNV and USUV neutralizing antibody titres
were determined by MNT on Vero cells in 96-well cell
culture plates, following the protocol described in Beck
et al. [31], withWNV strain IS-98-ST1 andUSUV strain
SAAR-1776 (South Africa). The MNT results were
interpreted according to the following rules: (i) if the
WNV antibody titre was strictly greater than the
USUV antibody titre, the serum was classiﬁed WNV
positive, (ii) if the WNV antibody titre was strictly
lower than theUSUVantibody titre, the serumwas clas-
siﬁed USUV positive, and (iii) if both antibody titres
were identical (and >0), the serumwas classiﬁed positive
for an undetermined ﬂavivirus.
Statistical analyses
Site- and species-speciﬁc seroprevalence rates were com-
puted, as well as their 95% conﬁdence intervals (CIs).
Horse and dog seroprevalence rates were compared in
order to evaluate the relevance of dogs as sentinel species
for the circulation of ﬂaviviruses. However, because ex-
posure to ﬂaviviruses was likely to vary across military
sites, the individual exposure of a given animal varied be-
tween animals, according to their successive postings
during their military careers. Species-speciﬁc prevalence
rates could thus not be directly compared and a multi-
variate logistic model was used to control this confound-
ing factor when analysing the relationship between
seropositivity and species. The dependent variable was
the cELISA result (positive or negative). Explanatory
variables were the species (horse or dog) and its inter-
action with the genus (as housing conditions differed
according to the genus in horses but not in dogs), the vac-
cination status, the potential exposure to WNV circula-
tion during reported epizootics (three binary variables
indicating whether the animal was born before the
reported epizootics of 1996, 2003 and 2010), and the
time spent by the animal in the various military sites of
Morocco (one quantitative variable for each of the vari-
ous military sites, plus a supplementary variable for the
time spent by the animal in Morocco before its integra-
tion into the Moroccan Army) (Fig. 1). The latter vari-
ables both represented variations across sites of the
level of viral circulation, and differences of animal
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exposure to mosquito bites between sites (due to differ-
ences of housing conditions and/or to geographical var-
iations of mosquito abundance).
RESULTS
Three hundred and forty-nine military horses and 231
dogs were included in the study.
Eighty-three percent (289/349) of the tested horses ori-
ginated from Moroccan studs, the remainder from
European studs. After their integration in the army,
horses were stationed at up to three military sites, but
the majority (88%, 307 animals) were stationed at a sin-
gle location. The age of horses varied between 18months
and 32 years, with an average of 14·5 years. Most ani-
mals had been vaccinated (88%, 308 animals) against
WNV with a canarypox-vectored vaccine expressing
the premembrane (prM) and envelope (E) genes of
WNV (Recombitek® rWNV vaccine, Merial, USA). A
single vaccine injection was administered for most (n=
212) animals and the others received one boost 3months
later. The single or last vaccine injection was performed,
on average, 16 months before the blood samples were
taken (range 13–17 months).
Fifty-nine percent of dogs had been born in a mili-
tary site (137/231), others originated from European
breeders. Dogs had been successively stationed at 1–5
sites, but most had been stationed at one (67%, 155 ani-
mals) or two (23%, 54 animals) sites. The average age
of dogs was 4·5 years (range 6 months to 13 years).
The overall cELISA seroprevalence rate was 60% in
horses (95% CI 55–65) and 62% in dogs (95% CI 55–
68) (Table 1). Among sites with 520 tested sera (ﬁve
sites for horses and two sites for dogs), the seropreva-
lence rate ranged between 29% (Khenifra) and 94%
(Temara) in horses, and between 54% (Benslimane)
and 96% (Kenitra) in dogs. Similar prevalence rates
were obtained when restricting the dataset to animals
which had been born in a military site (or which had
been imported there from Europe), and which had
remained there throughout their military career. For
example, 95% of horses that had always lived at the
Temara site were cELISA positive (42/44 animals),
compared to an overall seroprevalence of 94%.
Antibodies directed againstWNVNS1 proteinwere
detected in 79% of tested horse sera (72/91, 95%CI 69–
87) suggesting that most cELISA-positive results were
due toWNV infection. No signiﬁcant difference in the
proportion of NS1-ELISA-positive sera was observed
between vaccinated and non-vaccinated animals
(Fisher’s test, P > 0·05).
In horses, 74% (78/106) of cELISA-positive sera
were found to be WNF positive by seroneutralization,
4% (4/106) USUV positive, and 2% (2/106) were clas-
siﬁed positive for an undetermined ﬂavivirus.
Twenty-one percent (22/106) were negative for both
viruses (Table 2). For dogs, 80% (48/60) of
cELISA-positive sera were positive for WNV by sero-
neutralization, 12% (7/60) for USUV, and 8% (5/60)
were classiﬁed positive for an undetermined ﬂavivirus.
None of the cELISA-positive sera were negative for
both viruses (Table 2).
The multivariate model did not show any signiﬁ-
cant effect of the species on cELISA seropositivity
risk (Table 3). Conversely, a birth date before
September 2010 (and having thus been potentially
exposed to the 2010 WNV epizootic) was a seroposi-
tivity risk factor [odds ratio (OR) 7·4]. Being a stallion
induced a protective effect (OR 0·3), probably because
stallions are kept in housing conditions where they are
less likely to be exposed to mosquito bites. Finally,
having been stationed at Kenitra and Temara were
seropositivity risk factors (OR 1·4 and 1·3, respectively,
for a posting of 1 year).
DISCUSSION
The serological results reported here indicate a large
geographical distribution of ﬂaviviruses in Morocco.
A seroprevalence rate of 60% has been observed in
military working horses, which lies between values
reported in sub-Saharan African countries such as
Senegal (85% [32]) where WNV is considered endem-
ic, and European countries such as Spain (7% in
Andalusia [33] and 8% in Doñana [34]) or France
(8·5% in the Camargue area [35] and 34% in the Var
department [36]).
High seroprevalence rates were observed in pro-
vinces where clinical cases had been previously
reported in horses, such as Kenitra (82%). This result
may be compared with the seroprevalence rate of 19%
observed in sera collected 12 months earlier from
humans living in the same area [5]. The geographical
distribution of ﬂavivirus was, however, not limited
to areas where clinical cases had been previously
reported. Indeed, the highest seroprevalence rate
observed in horses was obtained for the Temara site,
located in an area from where no WNF case has
ever been reported (although the province of Temara
is close to areas affected in 1996, 2003 or 2010). For
this site, the horse seroprevalence rate was 94%, and
95% when considering only animals that had always
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lived there. Similarly, whereas no WNF case has ever
been reported in Meknes province, the horse sero-
prevalence rate was 34%, compared to the seropreva-
lence rate of 5% obtained in humans in the same area
12 months earlier [5].
Most of the tested horses had been vaccinated
against WNV and some cELISA-positive results may
be attributed to vaccine-induced antibodies. However,
vaccine-induced antibodies have a shorter half-life
than WNV-induced antibodies, as they are usually
detected up to 300 days post-injection [37]. All of the
tested horses had received the last vaccine injection
>400 days before blood samples were taken, and most
had received a single vaccine injection, in 2010. Thema-
jority of the cELISA-positive results are thus probably
attributable to natural antibodies, which is conﬁrmed
by the 79% of cELISA-positive sera that tested positive
using aWNV-DIVA test (detection of antibodies direc-
ted against WNVNS1 protein, which was not included
in the WNV vaccine used). Discordant cELISA-posi-
tive and NS1-ELISA negative results could be due to
prior and confounding vaccination, but also to other
factors. Weakly WNV-positive sera may give
NS1-ELISA-negative results: four NS1-ELISA-nega-
tive sera had a cELISA S/N value between 30% and
40%, and seven had a cELISA S/N value between
20% and 30% (data not shown). Infection with a ﬂavi-
virus different fromWNVmay also explain discordant
results, as theNS1-ELISA is farmore speciﬁc forWNV
antibodies than WNV cELISA: indeed, two
NS1-ELISA-negative horses were found to have anti-
bodies to USUV (data not shown). Seroneutralization
test results indicate that most of the cELISA-positive
results observed in horses were due to WNV (74%),
few sera being classiﬁed USUV positive (4%).
Twenty-two samples were MNT negative and corre-
sponded to samples with low anti-ﬂavivirus response
(low positives by cELISA), conﬁrming the previously
lower sensitivity of MNT [38].
The overall cELISA seroprevalence rate obtained in
dogs (62%) was remarkably close to that obtained in
horses (60%), and site-speciﬁc seroprevalence rates
observed in dogs were close to those observed in
horses. As for horses, seroneutralization results indi-
cate a predominant exposure of dogs to WNV
(80%); however, a signiﬁcant proportion of sera were
classiﬁed USUV positive (12%). The multivariate
model did not show any signiﬁcant effect of the spe-
cies on cELISA status, despite several expected effects
on the seropositivity risk. For example, two variables
describing an exposure to previous epizootics were
seropositivity risk factors: being born before the last
Table 2. Comparison of seroneutralization titres against WNV and USUV in military working horses and dogs,
Morocco, 2012
WNV
Horses Negative 10 30 90 270 810 Total Conclusion
USUV Negative 22 17 20 17 1 0 77 (55a-0b-0c)
10 0 0 1 11 6 0 18 (18-0-0)
30 1 0 2 0 3 2 8 (5-1-2)
90 0 0 1 0 0 0 1 (0-1-0)
270 0 0 2 0 0 0 2 (0-2-0)
810 0 0 0 0 0 0 0 (0-0-0)
Total 23 17 26 28 10 2 106 (78-4-2)
Dogs Negative 10 30 90 270 810 Total Conclusion
USUV Negative 0 1 3 0 0 0 4 (4-0-0)
10 2 0 3 3 0 0 8 (6-2-0)
30 2 0 4 24 7 1 38 (32-2-4)
90 2 0 0 0 5 1 8 (6-2-0)
270 0 0 1 0 1 0 2 (0-1-1)
810 0 0 0 0 0 0 0 (0-0-0)
Total 6 1 11 27 13 2 60 (48-7-5)
WNV, West Nile virus; USUV, Usutu virus
a Number of sera classiﬁed WNV positive (WNV titre >USUV titre, numbers in plain font).
b Number of sera classiﬁed USUV positive (WNV titre <USUV titre, numbers in italics).
c Number of sera classiﬁed positive for an undetermined ﬂavivirus (WNV titre =USUV titre and WNV titre > 0, numbers in
bold). Underlined: sera classiﬁed negative for WNV and USUV.
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WNF epizootic of 2010, and having been stationed at
Kenitra (i.e. in a province where WNF cases had been
reported in 1996, 2003 and 2010). Similarly, a variable
linked to housing conditions with a lower exposure to
mosquito bites (i.e. being a stallion) was a protective
factor. The fact that military working dogs moved
on average more often than horses between military
sites complicated the comparison of seroprevalence
between the species, but the multivariate model
allowed this confounding factor to be controlled for.
Therefore our results suggest that, under similar expos-
ure conditions tomosquito bites, theWNV seropositiv-
ity risk in dogs and horses is similar. Considering the
shorter lifespan of dogs, this may indicate a stronger ex-
posure of dogs than horses tomosquito bites, which is in
line with results obtained in Europe (Barcelona, Spain),
where bloodmeal analysis of Culex pipiens has shown
that this vector of WNV had often acquired blood
from dogs [39], and in the United States where similar
results have been obtained for Culex quinquefasciatus
and Aedes albopictus [40, 41].
In conclusion, our study reveals a large geographic-
al distribution of WNV circulation in Morocco, and
the ﬁrst evidence of USUV circulation in Morocco
in horses and dogs. The similar seroprevalence rates
observed in military working dogs and horses suggest
that dogs may be a relevant choice for serological sur-
veillance of WNV or USUV circulation, especially in
areas where equine vaccination precludes passive sur-
veillance (based on the detection of WNF cases) in
horses. However, whether a dog-based sentinel sur-
veillance system would enable early detection of
WNV circulation remains to be investigated.
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Temara 0·001 1·3 (1·1–1·5)
Saﬁ n.s.
Unknown* n.s.
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